scholarly journals Dimension reduction and estimation in the secondary analysis of case-control studies

2018 ◽  
Vol 12 (1) ◽  
pp. 1782-1821
Author(s):  
Liang Liang ◽  
Raymond Carroll ◽  
Yanyuan Ma
Keyword(s):  
Dimension Reduction ◽  
Secondary Analysis ◽  
Case Control ◽  
Case Control Studies

scholarly journals A Dimension Reduction Approach for Modeling Multi-Locus Interaction in Case-Control Studies

2011 ◽  
Vol 71 (4) ◽  
pp. 234-245 ◽  
Author(s):  
Saonli Basu ◽  
Wei Pan ◽  
William S. Oetting
Keyword(s):  
Dimension Reduction ◽  
Case Control ◽  
Case Control Studies ◽  
Reduction Approach

Case-Control Studies

2009 ◽  
Author(s):  
Ruth H. Keogh ◽  
D. R. Cox
Keyword(s):  
Case Control ◽  
Case Control Studies

Clinical Trials in Thrombosis: Secondary Prevention of Myocardial Infarction

1976 ◽  
Vol 35 (01) ◽  
pp. 049-056 ◽  
Author(s):  
Christian R Klimt ◽  
P. H Doub ◽  
Nancy H Doub
Keyword(s):  
Myocardial Infarction ◽  
Secondary Prevention ◽  
Case Control ◽  
Therapeutic Effects ◽  
Case Control Studies ◽  
Definitive Answer ◽  
Inhibition Of Platelet Aggregation ◽  
Prospective Trials

SummaryNumerous in vivo and in vitro experiments, investigating the inhibition of platelet aggregation and the prevention of experimentally-induced thrombosis, suggest that anti-platelet drugs, such as aspirin or the combination of aspirin and dipyridamole or sulfinpyrazone, may be effective anti-thrombotic agents in man. Since 1971, seven randomized prospective trials and two case-control studies have been referenced in the literature or are currently being conducted, which evaluate the effects of aspirin, sulfinpyrazone, or dipyridamole in combination with aspirin in the secondary prevention of myocardial infarction. A critical review of these trials indicates a range of evidence from no difference to a favorable trend that antiplatelet drugs may serve as anti-thrombotic agents in man. To date, a definitive answer concerning the therapeutic effects of these drugs in the secondary prevention of coronary heart disease is not available.

Sign in / Sign up

Export Citation Format

Share Document